Sign In
Buy PTX
$0.0289
+0 (+0%)
At Close: Sep 17, 2019
PTX Metals (PTX) Opens the Market
11:17am, Friday, 25'th Apr 2025
Toronto, Ontario--(Newsfile Corp. - April 25, 2025) - Greg Ferron, Chief Executive Officer and President, PTX Metals (TSXV: PTX) ("PTX" or the "Company"), joined Tim Babcock, President, TSX Venture Ex
PTX Metals' Green Canada Subsidiary Announces Acquisition of Thelon Basin Uranium Claims
08:37am, Wednesday, 25'th Sep 2024
TORONTO, Sept. 25, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a minerals exploration Company focused on high-quality gold, co
PTX Metals Announces Appointment of Frederico Marques to the Board of Directors
08:30am, Wednesday, 11'th Sep 2024
TORONTO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a minerals exploration Company focused on high-quality gold, co
PTX Metals Inc. Announces Effective Date of Share Consolidation
08:00am, Friday, 06'th Sep 2024
TORONTO, Sept. 06, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PF) (“PTX Metals” or the “Company”) announces that it will consolidate its common shares (the
PTX Metals Inc. Announces Share Consolidation
07:45pm, Tuesday, 03'rd Sep 2024
TORONTO, Sept. 03, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PF) (“PTX Metals” or the “Company”) announces that it will be proceeding with the consolidati
PTX Metals Announces High Grade Gold Exploration Results From South Timmins Projects
08:50am, Thursday, 08'th Aug 2024
TORONTO, Aug. 08, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a minerals exploration Company with two flagship projects situat
PTX Metals Comments on Recent Promotional Activity Pursuant to OTC Markets' Request
05:00pm, Tuesday, 06'th Aug 2024
TORONTO, Aug. 06, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”), a minerals exploration Company with two flagship projects situat
PTX Metals Announces Additional Wide Zones of Near Surface Copper Nickel PGE Mineralization at W2 Project
08:00am, Tuesday, 30'th Jul 2024
TORONTO, July 30, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”) is pleased to announce additional drill results from the 1,544
TORONTO, July 24, 2024 (GLOBE NEWSWIRE) -- PTX Metals Inc. (CSE: PTX) (OTCQB: PANXF, Frankfurt: 9PX) (“PTX” or the “Company”) is pleased to provide partial drill results from the 1,544 metre
Pernix Therapeutics Provides Business Update
04:01pm, Wednesday, 15'th Apr 2015
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX) (the "Company"), a specialty pharmaceutical company, today updated its full-year 2015 net sales guidance and business
Pernix to Acquire Zohydro® ER Franchise from Zogenix, Inc.
04:05pm, Tuesday, 10'th Mar 2015
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Ireland Limited, a wholly owned subsidiary of Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, announced today that it has
CORRECTING and REPLACING Pernix Therapeutics Exceeds 2014 Revenue Guidance: Delivers FY2014 Net Revenue In Excess of $120 Million
10:14am, Tuesday, 20'th Jan 2015
MORRISTOWN, N.J.--(BUSINESS WIRE)--Subhead of release should read: Company to host a Conference Call and Webcast on Wednesday, February 25th beginning at 10:00 a.m. EST to report 4Q and FY2014 Financi
Pernix Therapeutics to Report Q3 2014 Financial Results
08:45am, Monday, 27'th Oct 2014
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ:PTX), a specialty pharmaceutical company, today announced that it will release its third quarter 2014 financial results on
Pernix Therapeutics Closes Acquisition of Treximet. Raises $220m Senior Notes. Issues Updated 2014 Guidance.
08:00am, Wednesday, 20'th Aug 2014
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ GM: PTX) (“Pernix” or the “Company”), a specialty pharmaceutical company, announced today that it has closed its a
Pernix Therapeutics to Report Second Quarter 2014 Financial Results on August 11, 2014
09:00am, Friday, 25'th Jul 2014
MORRISTOWN, N.J.--(BUSINESS WIRE)--Pernix Therapeutics Holdings, Inc. (NASDAQ: PTX), a specialty pharmaceutical company, today announced that it will release its second quarter 2014 financial results
